Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

DXCM - Dexcom Inc


IEX Last Trade
69.31
-0.310   -0.447%

Share volume: 4,612,819
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$69.62
-0.31
-0.45%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
60%
Profitability 85%
Dept financing 25%
Liquidity 46%
Performance 49%
Company vs Stock growth
vs
Performance
5 Days
-6.39%
1 Month
-0.52%
3 Months
-41.44%
6 Months
-39.29%
1 Year
-32.95%
2 Year
-16.20%
Key data
Stock price
$69.31
P/E Ratio 
41.67
DAY RANGE
N/A - N/A
EPS 
$1.58
52 WEEK RANGE
$62.34 - $142.00
52 WEEK CHANGE
-$0.32
MARKET CAP 
27.786 B
YIELD 
N/A
SHARES OUTSTANDING 
400.727 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/24/2024
BETA 
0.48
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,648,214
AVERAGE 30 VOLUME 
$5,221,023
Company detail
CEO: Kevin Sayer
Region: US
Website: http://www.dexcom.com/
Employees: 5,328
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

founded in 1999, dexcom, inc provides continuous glucose monitoring technology to help patients and their clinicians better manage diabetes. since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions for people with diabetes — while empowering our community to take control of diabetes.

Recent news